Chronic Obstructive Pulmonary DiseasePICCOPD+NCT01648621
Program of Integrated Care for Patients With Chronic Obstructive Pulmonary Disease and Multiple Comorbidities
A study testing 40 minute standardized education session, Individualized action plan and Individualized care plan in people with Chronic Obstructive Pulmonary Disease and Multiple Comorbidity, run by Michael Garron Hospital at 2 sites in Canada.
Trial summary
Many patients with chronic obstructive pulmonary disease (COPD) also have other diseases referred to as comorbidities. Often these patients require health care by a variety of health care professionals from services linked to hospitals and in the community. Read more about this study
- Who is it for?
- Ages 50 years and older
- Conditions the study is for
- Chronic Obstructive Pulmonary Disease, Multiple Comorbidity
- What is being tested?
- 40 minute standardized education session, Individualized action plan and Individualized care plan
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 470 participants
- Where
- 2 sitesCanada
- Study dates
- Aug 2012to Dec 2015
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 50 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- COPD defined as chronic irreversible airflow limitation with FEV1 < lower limit of normal for age as % predicted and a FEV1/FVC ratio < than lower limit of normal (usually 70%) [5]
- Plus ≥ 2 comorbidities commonly associated with COPD as identified in the Canadian Thoracic Society COPD guidelines
- Cardiovascular disease
- Osteopenia and osteoporosis
- Glaucoma and cataracts
- Cachexia and malnutrition
Show all 18Show fewer
- Peripheral muscle dysfunction
- Lung cancer
- Metabolic syndrome (diabetes mellitus)
- Depression
- Chronic kidney disease OR Other conditions as primary admitting/presenting diagnosis + COPD as significant comorbidity + ≥ 1 other comorbidity
- THAT
- Get admitted to participating hospital; or
- Present to participating hospital ED; or
- Have first referral to Respiratory Centre/Respirology team
- AND HAVE
- ≥ 1 ED presentation/hospital admission in previous 12 months
- ≥ 50 years age
Who cannot join
- No access to primary care physician
- Primary diagnosis of asthma
- Terminal diagnosis (metastatic disease with a life expectancy of ≤ 6 months)
- Dementia and absence of family caregiver able to assist with activation of the action plan and feedback on ongoing status and care coordination
- Uncontrolled psychiatric illness
- Inability to understand, read, and write English
- No access to a phone
- Inability to attend follow up at one of the participating sites
Trial locations and contacts
2 sites in 1 country.
Canada2 sites
Southlake Regional Heath Centre
Newmarket, Ontario, L3Y 2P9
Toronto East General Hospital
Toronto, Ontario, M4C 3E7
About this study
Official title: Program of Integrated Care for Patients With Chronic Obstructive Pulmonary Disease and Multiple Comorbidities: A Randomized Controlled Trial
Many patients with chronic obstructive pulmonary disease (COPD) also have other diseases referred to as comorbidities. Often these patients require health care by a variety of health care professionals from services linked to hospitals and in the community. Unfortunately, sometimes it may be difficult for these patients to receive appropriate care in a timely manner resulting in a trip to the emergency department. As well, patients may benefit from education that enables them to recognize early signs indicating they are getting sicker and to self-manage their disease. Our study will examine a strategy that includes a case manager who will make weekly phone contact with COPD patients with comorbidity that present either to the emergency department or are admitted to hospital. Weekly contact will focus on teaching patients to recognize worsening symptoms and self-management strategies. The case manager will work with patients, caregivers, community health care providers and hospital specialists to promote communication and optimize care delivery. The investigators will examine the impact of our intervention on the need for emergency department visits and hospital admission. The investigators will also examine the impact on patients' health related quality of life, number of COPD exacerbations, and disease progression.
- Being tested
- 40 minute standardized education session, Individualized action plan, Individualized care plan, Standardized reinforcement/motivational interviewing and action plan teach-back sessions, Tele-home monitoring
- Keywords
- COPD, case management
- Medical subject headings
- Pulmonary Disease, Chronic Obstructive
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
40 minute standardized education sessionBehavioural
40 minute standardized education session based on the Living Well with COPD Patient's Education Tool on study enrolment to assess and improve understanding of disease and ability to monitor symptoms and recognize exacerbation
Individualized action planBehavioural
Individualized action plan using the Living Well with COPD template with patient individualized modification to address management strategies for exacerbation of comorbidity developed during the initial 40 minute session with case manager.
Individualized care planBehavioural
Individualized care plan for management of COPD and comorbidities developed by the case manager in consultation with family physician and specialists.
Standardized reinforcement/motivational interviewing and action plan teach-back sessionsBehavioural
Standardized reinforcement/motivational interviewing and action plan teach-back sessions based on Living Well with COPD modules as well as assessment of symptoms, progress and problems, and problem solving by phone weekly for 12 weeks, then monthly for 9 months (21 sessions) (telephone script; NOTE: case managers will make up to 3 attempts to contact participants during each week of the 12 weeks of weekly phone calls before determining inability to contact the participant for that week.
Tele-home monitoringBehavioural
Tele-home monitoring of SpO2, weight, dyspnea, sputum quantity and characteristics, and general well-being for maximum of 6 months.
Inclusion criteria for tele-home monitoring:
- compatible phone line b. patient consent c. patient or caregiver demonstrated ability to use monitoring equipment d. patient unable to attend outpatient/community appointments for assessment and monitoring because of environmental barriers to access (e.g. physician's office only accessible by stairs) e. severe dyspnea on activities of daily living (Medical Research Council Questionnaire for Assessing Severity of Breathlessness [MRC] Class 4 \& 5 or modified MRC [mMRC] 3 \& 4) f. frequent ED visits (> 2) in last 12 months
- 12 weeks of clinical stability with no ED visits.
Coordinated and improved communicationBehavioural
Coordinated and improved communication between the patient, family caregivers, family physicians, specialists, and Community Care Access Centres (CCACs) facilitated by the case manager. This will include phone contact by case manager to family physicians and CCAC case manager if applicable after initial enrollment, education session and development of action plan, then monthly to report general status as well as after subsequent ED presentations/hospital admissions
Priority accessBehavioural
Priority access to ambulatory clinics (Respirology and other specialties as required including Psychiatry) facilitated through the case manager.
Dictated patient summaryBehavioural
Dictated patient summary sent by specialists (e.g. respirologists) to family physicians following each respiratory centre visit (every 12 weeks)
in-hospital rehabilitation/self-management programBehavioural
Referral to an 8 week in-hospital rehabilitation and self-management education program for patients that are:
- have had a recent exacerbation, but are now clinically stable;
- symptomatic COPD including reduced activity levels and increased dyspnea despite pharmacological treatment;
- have stabilized comorbidity (no evidence of active ischemic, musculoskeletal, psychiatric or other systemic disease); and
- have sufficient motivation to participate.
Smoking cessationBehavioural
Referral to a smoking cessation program (as applicable)
Action plan RespirologistBehavioural
Individualized action plan developed with treating respirologist at the discretion of the attending respirologist.
Web based self management materialsBehavioural
Referral to educational materials and resources (Living Well with COPD module printouts provided during COPD rehabilitation classes at a cost to the individual)
| Study group | Role | What they receive |
|---|---|---|
| Case Management | Experimental | In addition to usual care, the intervention group will receive case management that includes: 40 minute standardized education session, an individualized action plan, an individualized care plan for management of COPD and comorbidities, standardized reinforcement/motivational interviewing and action plan teach-back sessions and assessment of symptoms, progress and problems, and problem solving by phone weekly for 12 weeks, then monthly for 9 months (21 sessions), tele-home monitoring, coordinated and improved communication between the patient, family caregivers, family physicians, specialists, and CCAC facilitated by the case manager, priority access to ambulatory clinics. Receives: Behavioral: 40 minute standardized education session; Behavioral: Individualized action plan; Behavioral: Individualized care plan; Behavioral: Standardized reinforcement/motivational interviewing and action plan teach-back sessions; Behavioral: Tele-home monitoring; Behavioral: Coordinated and improved communication; Behavioral: Priority access; Behavioral: Dictated patient summary; Behavioral: in-hospital rehabilitation/self-management program; Behavioral: Smoking cessation |
| Usual care | Active comparator | Usual care for these patients comprises: Dictated patient summary, referral to an 8 week in-hospital rehabilitation and self-management education program, referral to a smoking cessation program (as applicable), individualized action plan developed with treating respirologist at the discretion of the attending respirologist, Referral to web based educational materials and resources. Receives: Behavioral: Dictated patient summary; Behavioral: in-hospital rehabilitation/self-management program; Behavioral: Smoking cessation; Behavioral: Action plan Respirologist; Behavioral: Web based self management materials |
What is being measured
The primary outcome is the main question the study is designed to answer.
The number of ED presentations
Measured: 1 year after randomization.
Secondary outcomes (8)
Hospital admission rates
Measured: 1 year after randomization
Number of hospitalized days over 1 year
Measured: At one year after randomization
Time to death
Measured: During 12 months of intervention
COPD severity measured by the BODE index
The BODE Index is a simple grading system for COPD comprising the Six Minute Walk Distance (6MWD), the Medical Research Council Dyspnea Scale (MMRC) and body mass index (BMI).
Measured: at baseline, 6 months and 1 year
Change in health-related quality of life
Measured using the EQ5D, St George's Respiratory Questionnaire, Hospital Anxiety and Depression Scale (HADS)
Measured: baseline at 90 days, 6 months and 1 year
Change in COPD self-efficacy scale
The COPD SES provides items with sufficient complexity in relation to the specific situation of managing with COPD. The CSES consists of Likert scale with 5 responses from "very confident" to "not at all confident" scoring 5 to 1 with 5 representing higher self-efficacy.
Measured: baseline at 90 days, 6 months and 1 year
Patient satisfaction using the CSQ8
Measured: 90 days, 6 months and 1 year
Caregiver impact (Caregiver Impact Scale)
This questionnaire assesses the impact of caregiving on 14 different domains (health, employment, family relations), using a 7-point Likert scale.
Measured: at baseline, 6 months and 1 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted24 Jul 2012 (estimated)
- Study startAug 2012
- Primary completionDec 2015
- Study completionDec 2015
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for Chronic Obstructive Pulmonary DiseaseStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 470 participants (actual)
Sponsor and investigators
- Lead sponsor
- Michael Garron Hospital
- Sponsor type
- University, hospital or other
- Collaborators
- Southlake Health, University of Toronto, Ontario Ministry of Health and Long Term Care
- Responsible party
- Principal investigator, Louise Rose, Michael Garron Hospital
- Investigators
- Louise Rose, PhD, Principal investigator, Toronto East General Hospital/University of TorontoIan Fraser, MD, Principal investigator, Michael Garron Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01648621
- Sponsor's protocol ID
- TEGH001 PIC COPD
- Acronym
- PICCOPD+
- Status last verified
- Nov 2016
- First submitted
- 19 Jul 2012
- Last updated
- 11 Nov 2016
- Results posted
- No
- Data monitoring committee
- Yes
Publications
Poot CC, Meijer E, Kruis AL, Smidt N, Chavannes NH, Honkoop PJ. Integrated disease management interventions for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2021 Sep 8;9(9):CD009437. doi: 10.1002/14651858.CD009437.pub3.
PubMed 34495549Rose L, Istanboulian L, Carriere L, Thomas A, Lee HB, Rezaie S, Shafai R, Fraser I. Program of Integrated Care for Patients with Chronic Obstructive Pulmonary Disease and Multiple Comorbidities (PIC COPD+): a randomised controlled trial. Eur Respir J. 2018 Jan 11;51(1):1701567. doi: 10.1183/13993003.01567-2017. Print 2018 Jan.
PubMed 29326330
Study at a glance
From the registry record, last updated by the sponsor on 11 Nov 2016. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Program of Integrated Care for Patients With Chronic Obstructive Pulmonary Disease and Multiple Comorbidities: A Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT01648621
- Acronym / sponsor ID
- PICCOPD+ / TEGH001 PIC COPD
- Keywords
- COPD, case management
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 470 participants (actual)
- Lead sponsor
- Michael Garron HospitalUniversity, hospital or other
- Collaborators
- Southlake Health, University of Toronto, Ontario Ministry of Health and Long Term Care
- Study start
- Aug 2012
- Primary completion
- Dec 2015 (actual)
- Study completion
- Dec 2015 (actual)
- First posted
- 24 Jul 2012 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Many patients with chronic obstructive pulmonary disease (COPD) also have other diseases referred to as comorbidities. Often these patients require health care by a variety of health care professionals from services linked to hospitals and in the community. Unfortunately, sometimes it may be difficult for these patients to receive appropriate care in a timely manner resulting in a trip to the emergency department. As well, patients may benefit from education that enables them to recognize early signs indicating they are getting sicker and to self-manage their disease. Our study will examine a strategy that includes a case manager who will make weekly phone contact with COPD patients with comorbidity that present either to the emergency department or are admitted to hospital. Weekly contact will focus on teaching patients to recognize worsening symptoms and self-management strategies. The case manager will work with patients, caregivers, community health care providers and hospital specialists to promote communication and optimize care delivery. The investigators will examine the impact of our intervention on the need for emergency department visits and hospital admission. The investigators will also examine the impact on patients' health related quality of life, number of COPD exacerbations, and disease progression.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Case Management | Experimental | Behavioral: 40 minute standardized education session, Behavioral: Individualized action plan, Behavioral: Individualized care plan, Behavioral: Standardized reinforcement/motivational interviewing and action plan teach-back sessions, Behavioral: Tele-home monitoring, Behavioral: Coordinated and improved communication, Behavioral: Priority access, Behavioral: Dictated patient summary, Behavioral: in-hospital rehabilitation/self-management program, Behavioral: Smoking cessationIn addition to usual care, the intervention group will receive case management that includes: 40 minute standardized education session, an individualized action plan, an individualized care plan for management of COPD and comorbidities, standardized reinforcement/motivational interviewing and action plan teach-back sessions and assessment of symptoms, progress and problems, and problem solving by phone weekly for 12 weeks, then monthly for 9 months (21 sessions), tele-home monitoring, coordinated and improved communication between the patient, family caregivers, family physicians, specialists, and CCAC facilitated by the case manager, priority access to ambulatory clinics. |
| Usual care | Active comparator | Behavioral: Dictated patient summary, Behavioral: in-hospital rehabilitation/self-management program, Behavioral: Smoking cessation, Behavioral: Action plan Respirologist, Behavioral: Web based self management materialsUsual care for these patients comprises: Dictated patient summary, referral to an 8 week in-hospital rehabilitation and self-management education program, referral to a smoking cessation program (as applicable), individualized action plan developed with treating respirologist at the discretion of the attending respirologist, Referral to web based educational materials and resources. |
Who may qualify
- Ages
- 50 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (18 listed)
- COPD defined as chronic irreversible airflow limitation with FEV1 < lower limit of normal for age as % predicted and a FEV1/FVC ratio < than lower limit of normal (usually 70%) [5]
- Plus ≥ 2 comorbidities commonly associated with COPD as identified in the Canadian Thoracic Society COPD guidelines
- Cardiovascular disease
- Osteopenia and osteoporosis
- Glaucoma and cataracts
Key exclusion criteria (8 listed)
- No access to primary care physician
- Primary diagnosis of asthma
- Terminal diagnosis (metastatic disease with a life expectancy of ≤ 6 months)
- Dementia and absence of family caregiver able to assist with activation of the action plan and feedback on ongoing status and care coordination
- Uncontrolled psychiatric illness
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| 40 minute standardized education session40 minute standardized education session based on the Living Well with COPD Patient's Education Tool on study enrolment to assess and improve understanding of disease and ability to monitor symptoms and recognize exacerbation | Behavioural | Case Management |
| Individualized action planIndividualized action plan using the Living Well with COPD template with patient individualized modification to address management strategies for exacerbation of comorbidity developed during the initial 40 minute session with case manager. | Behavioural | Case Management |
| Individualized care planIndividualized care plan for management of COPD and comorbidities developed by the case manager in consultation with family physician and specialists. | Behavioural | Case Management |
| Standardized reinforcement/motivational interviewing and action plan teach-back sessionsStandardized reinforcement/motivational interviewing and action plan teach-back sessions based on Living Well with COPD modules as well as assessment of symptoms, progress and problems, and problem solving by phone weekly for 12 weeks, then monthly for 9 months (21 sessions) (telephone script; NOTE: case managers will make up to 3 attempts to contact participants during each week of the 12 weeks of weekly phone calls before determining inability to contact the participant for that week. | Behavioural | Case Management |
| Tele-home monitoringTele-home monitoring of SpO2, weight, dyspnea, sputum quantity and characteristics, and general well-being for maximum of 6 months. Inclusion criteria for tele-home monitoring: a. compatible phone line b. patient consent c. patient or caregiver demonstrated ability to use monitoring equipment d. patient unable to attend outpatient/community appointments for assessment and monitoring because of environmental barriers to access (e.g. physician's office only accessible by stairs) e. severe dyspnea on activities of daily living (Medical Research Council Questionnaire for Assessing Severity of Breathlessness [MRC] Class 4 \& 5 or modified MRC [mMRC] 3 \& 4) f. frequent ED visits (> 2) in last 12 months 5. 12 weeks of clinical stability with no ED visits. | Behavioural | Case Management |
| Coordinated and improved communicationCoordinated and improved communication between the patient, family caregivers, family physicians, specialists, and Community Care Access Centres (CCACs) facilitated by the case manager. This will include phone contact by case manager to family physicians and CCAC case manager if applicable after initial enrollment, education session and development of action plan, then monthly to report general status as well as after subsequent ED presentations/hospital admissions | Behavioural | Case Management |
| Priority accessPriority access to ambulatory clinics (Respirology and other specialties as required including Psychiatry) facilitated through the case manager. | Behavioural | Case Management |
| Dictated patient summaryDictated patient summary sent by specialists (e.g. respirologists) to family physicians following each respiratory centre visit (every 12 weeks) | Behavioural | Case Management, Usual care |
| in-hospital rehabilitation/self-management programReferral to an 8 week in-hospital rehabilitation and self-management education program for patients that are: 1. have had a recent exacerbation, but are now clinically stable; 2. symptomatic COPD including reduced activity levels and increased dyspnea despite pharmacological treatment; 3. have stabilized comorbidity (no evidence of active ischemic, musculoskeletal, psychiatric or other systemic disease); and 4. have sufficient motivation to participate. | Behavioural | Case Management, Usual care |
| Smoking cessationReferral to a smoking cessation program (as applicable) | Behavioural | Case Management, Usual care |
| Action plan RespirologistIndividualized action plan developed with treating respirologist at the discretion of the attending respirologist. | Behavioural | Usual care |
| Web based self management materialsReferral to educational materials and resources (Living Well with COPD module printouts provided during COPD rehabilitation classes at a cost to the individual) | Behavioural | Usual care |
Primary outcome
The number of ED presentations
Time frame: 1 year after randomization.
8 secondary outcomes
Hospital admission rates
Time frame: 1 year after randomization
Number of hospitalized days over 1 year
Time frame: At one year after randomization
Time to death
Time frame: During 12 months of intervention
COPD severity measured by the BODE index
Time frame: at baseline, 6 months and 1 year
Change in health-related quality of life
Time frame: baseline at 90 days, 6 months and 1 year
Change in COPD self-efficacy scale
Time frame: baseline at 90 days, 6 months and 1 year
Patient satisfaction using the CSQ8
Time frame: 90 days, 6 months and 1 year
Caregiver impact (Caregiver Impact Scale)
Time frame: at baseline, 6 months and 1 year
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 11 Nov 2016.
- Derived from this study: PubMed 34495549Poot CC, Meijer E, Kruis AL, Smidt N, Chavannes NH, Honkoop PJ. Integrated disease management interventions for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2021 Sep 8;9(9):CD009437. doi: 10.1002/14651858.CD009437.pub3.
- Derived from this study: PubMed 29326330Rose L, Istanboulian L, Carriere L, Thomas A, Lee HB, Rezaie S, Shafai R, Fraser I. Program of Integrated Care for Patients with Chronic Obstructive Pulmonary Disease and Multiple Comorbidities (PIC COPD+): a randomised controlled trial. Eur Respir J. 2018 Jan 11;51(1):1701567. doi: 10.1183/13993003.01567-2017. Print 2018 Jan.
Related trials for Chronic Obstructive Pulmonary Disease
Not yet recruitingPhase 1/2
cfMSC Stem Cell Therapy Targeting COPD
Chronic Obstructive Pulmonary Disease (COPD)
Recruiting
Multimodal Assessment of NMES Effects on Respiratory and Peripheral Muscles in COPD
Chronic Obstructive Pulmonary Disease (COPD), Respiratory Muscle Dysfunction
RecruitingPhase 2/3
A Study to Investigate the Efficacy and Safety of Zelicapavir Compared With Placebo in Adults With RSV Who Are at High Risk for Severe Disease
RSV
Enrolling by invitationObservational study
Firefighter's Longitudinal Airway and Respiratory Exposome/Multiome Study (FLARES)
Anosmia, Chronic Obstructive Pulmonary Disease
RecruitingObservational study
Construction and Validation of an Impulse Oscillometry (IOS)-Based Platform for Screening, Diagnosis, and Management of Chronic Airway Diseases
Chronic Obstructive Pulmonary Disease (COPD), Asthma (Diagnosis)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Louise Rose, PhD principal investigator
Toronto East General Hospital/University of Toronto
Ian Fraser, MD principal investigator
Michael Garron Hospital
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing 40 minute standardized education session, Individualized action plan and Individualized care plan in people with Chronic Obstructive Pulmonary Disease and Multiple Comorbidity, run by Michael Garron Hospital at 2 sites in Canada.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 18 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 11 Nov 2016. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
The number of ED presentations (time frame: 1 year after randomization.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT01648621, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Nov 2016.